Latest database descriptions

1- To characterise immunity response to influenza vaccination in accordance with intradermal or intramuscular injection 2- To characterise immunosenescence markers in populations with no response to influenza vaccines

General objective: to phenotype forms of familial retinal vein occlusion Secondary objective: to collect DNA

Collect of medical, medicosocial, economic, neuropsychological,biological and imaging information in young patients consulting at CNR-MAJ, with follow-up every 6 months until death. If specific consent has been granted, an autopsy for neuropathological confirmation of the diagnosis will be performed.
Primary objective
- To determine the diagnostic and medicosocial pathways followed by young patients suffering from
early onset dementia
Secondary objectives
- To evaluate factors associated with diagnostic delay
- To constitute clinical, imaging and biological resources for this dementia occuring in young subjects.

Objectives of the registry in terms of public health (surveillance, evaluation)
- Produce local statistics for institutions, particularly decision-makers,
researchers, associations and the general public, for describing the trends over time of the incidence
of cancers and their geographical distribution - with a view to planning and monitoring the efficacy of treatment
(prevalence, survival), for the investigation of clusters.
- Participate in producing national, regional (Francim) and international (IARC) statistics on
cancer: incidence, prevalence and survival.
- Evaluate the impact of public health measures (organized screening programs, regional
health programs).

Objectives of the registry in terms of research
- Evaluate medical practices and patient treatment through specific studies
conducted from exhaustive and non-biased data produced by the registry (high-
resolution studies).
- Develop etiological studies, particularly on professional and
environmental determining factors of cancer.
- Develop studies on the socioeconomic and clinical determining factors of the treatment
and survival of cancer patients.